Company acknowledged for excellence in employer-sponsored training and development programs

PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that the Company has been recognized among top U.S. businesses in Training magazine’s annual “Training Top 125.” This year marks the second time PAREXEL earned a place in the Training Top 125 for developing creative and effective learning and development initiatives for its global workforce.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170131005740/en/

PAREXEL's Albert Siu and Anke Nissen accept a 2017 Training magazine Training Top 125 award on behalf of the company. PAREXEL ranked 38 among the top 125 companies. (Photo: Business Wire)

“At PAREXEL, our employees are our core asset and give us our competitive edge. Developing their capabilities is a key component of our people strategy. From traditional instructor-led delivery to eLearning environments, PAREXEL provides best-in-class learning products and customized training programs,” said Albert Siu, Vice President, Learning and Development, PAREXEL. “Our focus is to deliver the right training, to the right people, at the right time to ensure our employees are prepared to succeed in their jobs and careers. Having expertly trained employees around the globe is essential in helping our clients bring new drugs to patients.”

PAREXEL’s comprehensive learning and training programs encompass four primary learning domains including: company culture and strategy; functional competencies; leadership development; and professional development. The Company’s Learning and Development organization is recognized for its effective and efficient training infrastructure. All delivered programs have a unique set of performance metrics to measure effectiveness across learning disciplines.

“PAREXEL impressed us with its training focus that aligns to the requirements and needs of the business, while offering employees valuable career and job skills development,” said Lorri Freifeld, editor-in-chief, Training magazine. “The competition was fierce this year, and PAREXEL’s global learning and development initiatives earned the Company this well-deserved spot in our 2017 ranking.”

In addition to training employees, PAREXEL is committed to developing the future, global biopharmaceutical workforce with courses specifically tailored to meet the growing talent needs of the clinical development market. Since 2001, the PAREXEL Academy has designed and implemented a wide range of learning and performance programs to teach clinical research management for learners outside of PAREXEL. The PAREXEL Academy has locations in Asia, Europe, and the United States. Since inception, more than 1,000 students have graduated from the Academy’s programs.

For more than 15 years, Training magazine, the leading business publication for learning and development professionals, has issued its annual “Training Top 125,” which ranks companies’ excellence in employer-sponsored training and development programs. The rankings are based on myriad benchmarking statistics such as total training budget as a percentage of payroll; number of training hours invested per employee; training results based on evaluation and measurement of outcomes and business impact; and workplace survey results. In addition, a detailed and formal peer review evaluation process is conducted to determine the final ranking outcomes.

About PAREXEL InternationalPAREXEL International Corporation is a leading global biopharmaceutical services company, providing a broad range of expertise-based clinical research, consulting, medical communications, and technology solutions and services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, and reimbursement. PAREXEL Informatics provides advanced technology solutions, including medical imaging, to facilitate the clinical development process. Headquartered near Boston, Massachusetts, PAREXEL has offices in 85 locations in 51 countries around the world, and had approximately 18,750 employees in the first quarter. For more information about PAREXEL International visit www.PAREXEL.com.

PAREXEL and PAREXEL Academy are trademarks or registered trademarks of PAREXEL International Corporation or its affiliates. All other trademarks are the property of their respective owners.

This release contains “forward-looking” statements regarding future results and events. For this purpose, any statements contained herein that are not statements of historical fact may be deemed forward-looking statements. Without limiting the foregoing, the words “believes,” “anticipates,” “plans,” “expects,” “intends,” “appears,” “estimates,” “projects,” “will,” “would,” “could,” “should,” “targets,” and similar expressions are also intended to identify forward-looking statements. The forward-looking statements in this release involve a number of risks and uncertainties. Such factors and others are discussed in the section entitled “Risk Factors” of the Company’s most recent Annual Report on Form 10-K and subsequent quarterly reports on Form 10-Q filed with the Securities and Exchange Commission, which “Risk Factors” discussion is incorporated by reference in this press release. The Company specifically disclaims any obligation to update these forward-looking statements in the future. These forward-looking statements should not be relied upon as representing the Company’s estimates or views as of any date subsequent to the date of this press release.

Media:Cristi BarnettTel.: +1 781-434-4019Email: Cristi.Barnett@PAREXEL.comorJenny Radloff, PAN CommunicationsTel: +1 617-502-4300Email: PAREXEL@pancomm.comorInvestors:Ronald AldridgeTel.: +1-781-434-4753Email: ron.aldridge@PAREXEL.com

Parexel (NASDAQ:PRXL)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Parexel Charts.
Parexel (NASDAQ:PRXL)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Parexel Charts.